Interruptions During Medication Administration: A Descriptive Study.

Interruptions decrease the efficiency of the medication administration process. In this study, interruptions were found in 63% of the medication passes on four medical-surgical units in a community hospital. However, interruptions do not always lead to negative outcomes.

Risk of Gastrointestinal Bleeding with Rivaroxaban: A Comparative Study with Warfarin.

Introduction. The risk of gastrointestinal (GI) bleeding with rivaroxaban has not been studied extensively. The aim of our study was to assess this risk in comparison to warfarin.

Gastrointestinal bleeding with dabigatran, a comparative study with warfarin: a multicenter experience.

Background/aims: The risk of gastrointestinal (GI) bleeding with dabigatran when compared to warfarin has been controversial in the literature. The aim of our study was to assess this risk with the use of dabigatran.

Methods: We examined the medical records of patients who were started on dabigatran or warfarin from October 2010 to October 2012.

Pain management after total knee arthroplasty: a case–control study of continuous nerve block therapy.

Background: Continuous femoral nerve block infusions (CFNBIs) have been found to both decrease patient postoperative pain and improve postoperative joint mobilization, both of which impact patient satisfaction, outcome, and length of stay. When we began the use of CFNBIs, we needed to create a policy, process, standing order form, and staff education plan as well as a means to maximize therapy efficacy and believed that a research study would best meet those needs.

Purpose: To evaluate the patient response to the institution of CFNBI therapy, identify process improvement areas, and suggest areas for future study.

Risk of gastrointestinal bleeding with dabigatran: a head-to-head comparative study with rivaroxaban.

Introduction: The risk of gastrointestinal (GI) bleeding of dabigatran and rivaroxaban is relatively unexplored. The aim of our study was to compare this risk in both drugs.

Methods: We examined the medical records of patients on either dabigatran or rivaroxaban from October 2010 to April 2013 in two hospitals.

Ischemic colitis: A forgotten entity. Results of a retrospective study in 118 patients.

Objective: The aim of our study was to document our 6-year experiences in identifying the clinical characteristics, laboratory findings, risk factors and the outcomes of patients with ischemic colitis (IC) in a community hospital setting.

Methods: The medical records of patients who were diagnosed with IC from 2007 to 2013 in two community hospitals were retrospectively reviewed. Their clinical characteristics, laboratory results, radiological, endoscopic and histological evidence, anatomic location of the lesion, comorbidities, concomitant use of drugs, and so on, were collected.

Risk factors of recurrent ischemic colitis: a multicenter retrospective study.

Background/aims: Recurrence of ischemic colitis (IC) has not been studied extensively. The aim of this study was to investigate the characteristics of recurrent IC in the community setting and to identify any risk factors.

Methods: We conducted a retrospective study in two community hospitals.